Uveitic Macular Edema: Treatment Update

Raquel Goldhardt; Bradley Simon Rosen

doi:10.1007/s40135-016-0090-3

Uveitic Macular Edema: Treatment Update

Raquel Goldhardt, Bradley Simon Rosen

Ophthalmology

Research output: Contribution to journal › Review article › peer-review

21 Scopus citations

Abstract

The aim of this review is to summarize recent developments in the treatment of uveitic macular edema (ME). ME represent a major cause of visual loss in uveitis and adequate management is crucial for the maintenance of useful vision in patients with chronic uveitis.

Original language	English (US)
Pages (from-to)	30-37
Number of pages	8
Journal	Current Ophthalmology Reports
Volume	4
Issue number	1
DOIs	https://doi.org/10.1007/s40135-016-0090-3
State	Published - Mar 1 2016

Keywords

Corticosteroids
Immunosuppressive therapy
Inflammation
Inflammatory edema
Uveitic macular edema
Uveitis

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1007/s40135-016-0090-3

Cite this

@article{7e4272461cd445d9ba1bed196e25c4b0,

title = "Uveitic Macular Edema: Treatment Update",

abstract = "The aim of this review is to summarize recent developments in the treatment of uveitic macular edema (ME). ME represent a major cause of visual loss in uveitis and adequate management is crucial for the maintenance of useful vision in patients with chronic uveitis.",

keywords = "Corticosteroids, Immunosuppressive therapy, Inflammation, Inflammatory edema, Uveitic macular edema, Uveitis",

author = "Raquel Goldhardt and Rosen, {Bradley Simon}",

note = "Publisher Copyright: {\textcopyright} 2016, Springer Science + Business Media New York.",

year = "2016",

month = mar,

day = "1",

doi = "10.1007/s40135-016-0090-3",

language = "English (US)",

volume = "4",

pages = "30--37",

journal = "Current Ophthalmology Reports",

issn = "2167-4868",

number = "1",

}

TY - JOUR

T1 - Uveitic Macular Edema

T2 - Treatment Update

AU - Goldhardt, Raquel

AU - Rosen, Bradley Simon

PY - 2016/3/1

Y1 - 2016/3/1

N2 - The aim of this review is to summarize recent developments in the treatment of uveitic macular edema (ME). ME represent a major cause of visual loss in uveitis and adequate management is crucial for the maintenance of useful vision in patients with chronic uveitis.

AB - The aim of this review is to summarize recent developments in the treatment of uveitic macular edema (ME). ME represent a major cause of visual loss in uveitis and adequate management is crucial for the maintenance of useful vision in patients with chronic uveitis.

KW - Corticosteroids

KW - Immunosuppressive therapy

KW - Inflammation

KW - Inflammatory edema

KW - Uveitic macular edema

KW - Uveitis

UR - http://www.scopus.com/inward/record.url?scp=85020368507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020368507&partnerID=8YFLogxK

U2 - 10.1007/s40135-016-0090-3

DO - 10.1007/s40135-016-0090-3

M3 - Review article

AN - SCOPUS:85020368507

VL - 4

SP - 30

EP - 37

JO - Current Ophthalmology Reports

JF - Current Ophthalmology Reports

SN - 2167-4868

IS - 1

ER -

Uveitic Macular Edema: Treatment Update

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this